Treatment of Splenic Marginal Zone Lymphoma with Rituximab Monotherapy in 59 Patients

被引：0
|
作者：
Kalpadakis, Christina H.
Pangalis, Gerassimos [2 ]
Vassilakopoulos, Theodoros P. [2 ]
Sachanas, Sotirios P. [3 ]
Kontopidou, Flora
Yiakoumis, Xanthi [3 ]
Kokoris, Styliani
Dimitriadou, Evangelia
Dimopoulou, Maria [5 ]
Moschogiannis, Maria [3 ]
Korkolopoulou, Penelope
Kyrtsonis, Marie-Christine [4 ]
Siakantaris, Marina [6 ]
Papadaki, Helen A. [1 ]
Angelopoulou, Maria K. [2 ]
机构：
[1] Univ Crete, Sch Med, Dept Hematol, Iraklion, Greece
[2] Univ Athens, Dept Hematol, Laikon Gen Hosp, Athens 11528, Greece
[3] Athens Med Ctr, Athens, Greece
[4] Univ Athens, Sch Med, Dept Propedeut & Internal Med 1, GR-11527 Athens, Greece
[5] Laikon Gen Hosp, Thalassemia Ctr, Athens, Greece
[6] Univ Athens, Dept Internal Med 1, Hematol Unit, Laikon Gen Hosp, Athens 11528, Greece
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1167 / 1167
页数：1
相关论文
共 50 条
  • [41] Efficacy of rituximab in autoimmune hemolytic anemia associated with splenic marginal zone lymphoma
    Claudio Fozza
    Antonio Galleu
    Maria Grazia Careddu
    Domenica Barbara Giannico
    Silvana Bonfigli
    Salvatore Contini
    Maurizio Longinotti
    Annals of Hematology, 2010, 89 : 113 - 114
  • [42] Efficacy of rituximab in autoimmune hemolytic anemia associated with splenic marginal zone lymphoma
    Fozza, Claudio
    Galleu, Antonio
    Careddu, Maria Grazia
    Giannico, Domenica Barbara
    Bonfigli, Silvana
    Contini, Salvatore
    Longinotti, Maurizio
    ANNALS OF HEMATOLOGY, 2010, 89 (01) : 113 - 114
  • [43] Significant efficacy of 2-CdA with or without rituximab in the treatment of splenic marginal zone lymphoma (SMZL)
    Cervetti, G.
    Galimberti, S.
    Sordi, E.
    Buda, G.
    Orciuolo, E.
    Cecconi, N.
    Petrini, M.
    ANNALS OF ONCOLOGY, 2010, 21 (04) : 851 - 854
  • [44] Rituximab monotherapy for splenic lymphoma with villous lymphocytes
    Rey, J.
    Ivanov, V.
    Elomari, Y.
    Coso, D.
    Gastaut, J.
    Bouabdallah, R.
    ANNALS OF ONCOLOGY, 2008, 19 : 228 - 228
  • [45] Comparative outcomes of splenectomy and rituximab-based chemotherapy in elderly patients with splenic marginal zone lymphoma
    Olszewski, Adam J.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [46] Rituximab monotherapy for splenic marginal zone lymphoma with villous lymphocytes: report on long-term disease control for two patients with recurrence after splenectomy
    Debiasi, Marcio
    Hehnemann, Marluce
    Garicochea, Bernardo
    SAO PAULO MEDICAL JOURNAL, 2010, 128 (06): : 375 - 377
  • [47] Comparison of immunohistochemical staining of splenic marginal zone hyperplasia and splenic marginal zone lymphoma
    Fillman, EP
    Burton, MP
    Ehsan, A
    Neuhauser, TS
    LABORATORY INVESTIGATION, 2003, 83 (01) : 232A - 232A
  • [48] Comparison of immunohistochemical staining of splenic marginal zone hyperplasia and splenic marginal zone lymphoma
    Fillman, EP
    Burton, MP
    Ehsan, A
    Neuhauser, TS
    MODERN PATHOLOGY, 2003, 16 (01) : 232A - 232A
  • [49] SPLENIC MARGINAL ZONE CELL LYMPHOMA
    SCHMID, C
    KIRKHAM, N
    DISS, T
    ISAACSON, PG
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1992, 16 (05) : 455 - 466
  • [50] A CASE WITH SPLENIC MARGINAL ZONE LYMPHOMA
    Cagliyan, G. Akgun
    LEUKEMIA RESEARCH, 2016, 49 : S34 - S34
12345